YHLO Medical Device Industrial Park in Hunan Start Construction

On July 25, 2022, the YHLO Medical Device Industrial Park was announced to start construction in Hunan Province.

The total area of construction is up to 200,000 square meters. It is estimated to be completed and put into production in July 2025. The park will be one of the research and development centres of the YHLO iModules Integration System for Immunoassay and the subsidiary brand Drawray microfluidics products. The new park will be the basic facility for YHLO’s further development.

The industrial park is the core part of the medical device industry cluster project in Xiangtan City, Hunan Province. The goal of this project is to build a national-level medical device innovation park that integrates the headquarters office, technology research and development, manufacturing, warehousing and logistics, and living facilities.

More information

Details

Longgang, Shenzhen, Guangdong Province, China

Shenzhen Yhlo Biotech Co., Ltd.

Associated Trend items

Breaking news! YHLO received FDA 510(k) clearance

YHLO iFlash 3000-C Chemiluminescence Analyzer and HCG Test Kit have received FDA 510(k) clearance. It is YHLO’s first 100% independently cleared by FDA.

Recently, YHLO iFlash 3000-C Chemiluminescence Analyzer and HCG Test Kit have received FDA 510(k) clearance. It is YHLO’s first 100% independently cleared by FDA. FDA clearance for In Vitro Diagnostic (IVD) products is a crucial regulatory step in the United States. When the FDA clears an IVD product, it means that the product has undergone a thorough evaluation and sign...

More information

YHLO Newest IVDR Certificate Extended to 72 Products

In August 2022, YHLO received the newest IVDR Certificate from BSI, one of the most reputable notified bodies for medical device CE certifications.

The IVDR certificate of YHLO covers additional 58 YHLO chemiluminescent immunoassay (CLIA) detection products including TSH, Cardiolipin IgG, AMH, CA 15-3, CK-MB, HSV-1 IgG etc. Until today, YHLO has obtained IVDR CE Certificate of 72 products, covering the autoimmunity, reproductive health, tumor markers, cardiac markers, infection detection fields and so forth. The Re...

More information

YHLO's National-level Key Project Officially Launched

The "R&D of High-performance Immune On-site Rapid Diagnosis System" project is an important part of the key special task of "Diagnostic and Treatment Equipment and Biomedical Materials" of the Chinese National Key R&D Plan.

On December 16th, YHLO in collaboration with Professor Zhou Zhou from Fuwai Hospital of the Chinese Academy of Medical Sciences, has taken the lead in the initiation of the "R&D of High-performance Immune On-site Rapid Diagnosis System" project. Aligned with the "Diagnostic Devices and Biomedical Materials" key task of the Chinese National Key R&D Program, this project a...

More information

Products associated

automatic immunoassay analyzer

iFlash 1800

automatic immunoassay analyzer

iFlash 3000

Compare

Remove all

Compare up to 10 products